Anticoagulant and Antithrombotic Actions of AVE5026, an Enriched Anti-Xa Hemisynthetic Ultra-Low-Molecular-Weight Heparin

Conclusions:
This superior safety efficacy index in animal models in comparison with other LMWH may translate into improved antithrombotic efficacy with decreased bleeding risk.

Source: Clinical and Applied Thrombosis/Hemostasis - August 4, 2014 Category: Hematology Authors: Hoppensteadt, D. A., Gray, A., Jeske, W. P., Walenga, J. M., Fareed, J. Tags: Original Articles Source Type: research